Neuphoria Therapeutics Inc. (NEUP): Shareholders' Equity
$24.60M
As of 2026-06-30
+3.8%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $24.60M | +29.5% | 2026-09-18, Balance as of period end |
| 2025-06-30 | $19.00M | +8.6% | 2026-09-18, Balance as of period end |
| 2024-06-30 | $17.49M | -20.5% | 2025-09-29, Balance as of period end |
| 2023-06-30 | $22.01M | n/a | 2024-09-30, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $24.60M | +29.5% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $5.67M | -74.1% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $29.71M | +92.4% |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $35.52M | -49.5% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $6.33M | -13.5% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $2.84M | n/m |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | -$30.15M | n/m |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $3.46M | -14.2% |
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | -$60.28M | n/m |
Compare NEUP, LGVN, SXTC, VTGN side by side · Screen every company in Pharmaceutical Preparations ↗